scispace - formally typeset
Open AccessJournal ArticleDOI

Mutation of the angiopoietin-1 gene (ANGPT1) associates with a new type of hereditary angioedema

Reads0
Chats0
TLDR
Angiopoietin‐1 impairment is associated with angioedema, and ANGPT1 variants can be the basis of HAE.
Abstract
Background Hereditary angioedema (HAE) is a rare genetic disease usually caused by mutation in the C1 inhibitor or the coagulation Factor XII gene. However, in a series of patients with HAE, no causative variants have been described, and the pathophysiology of the disease remains unknown (hereditary angioedema with yet unknown genetic defect [U-HAE]). Identification of causative genes in patients with U-HAE is valuable for understanding the cause of the disease. Objective We conducted genetic studies in Italian patients with U-HAE to identify novel causative genes. Methods Among patients belonging to 10 independent families and unrelated index patients with U-HAE recruited from the Italian Network for C1-INH-HAE (ITACA), we selected a large multiplex family with U-HAE and performed whole-exome sequencing. The angiopoietin-1 gene (ANGPT1) was investigated in all patients with familial or sporadic U-HAE. The effect of ANGPT1 variants was investigated by using in silico prediction and plasma and transfected cells from both patients and control subjects. Results We identified a missense mutation ( ANGPT1 , c.807G>T, p.A119S) in a family with U-HAE. The ANGPT1 p.A119S variant was detected in all members of the index family with U-HAE but not in asymptomatic family members or an additional 20 patients with familial U-HAE, 22 patients with sporadic U-HAE, and 200 control subjects. Protein analysis of the plasma of patients revealed a reduction of multimeric forms and a reduced ability to bind the natural receptor tunica interna endothelial cell kinase 2 of the ANGPT1 p.A119S variant. The recombinant mutated ANGPT1 p.A119S formed a reduced amount of multimers and showed reduced binding capability to its receptor. Conclusion ANGPT1 impairment is associated with angioedema, and ANGPT1 variants can be the basis of HAE.

read more

Citations
More filters
Journal ArticleDOI

Hereditary angioedema with a mutation in the plasminogen gene

TL;DR: This work sought to identify and characterize a hitherto unknown type of HAE with normal C1‐INH and without mutation in the F12 gene.
Journal ArticleDOI

Epidemiology of Bradykinin-mediated angioedema: a systematic investigation of epidemiological studies.

TL;DR: Assessment of the epidemiological burden of Bradykinin-mediated angioedema in the USA, Germany and France found ACEI-AE is more common than C1-INH-HAE (~ 10:1), which is moreCommon than C2-inhibitor related acquired angIOedema (~‬10: 1).
References
More filters
Journal ArticleDOI

Requisite Role of Angiopoietin-1, a Ligand for the TIE2 Receptor, during Embryonic Angiogenesis

TL;DR: It is shown that mice engineered to lack Angiopoietin-1 display angiogenic deficits reminiscent of those previously seen in mice lacking TIE2, demonstrating that AngiopOietIn-1 is a primary physiologic ligand for TIE1 and that it has critical in vivo angiogenesis actions that are distinct from VEGF and that are not reflected in the classic in vitro assays used to characterize VEGf.
Journal ArticleDOI

Leakage-resistant blood vessels in mice transgenically overexpressing angiopoietin-1.

TL;DR: Angiopoietin-1 may be useful for reducing microvascular leakage in diseases in which the leakage results from chronic inflammation or elevated V EGF and, in combination with VEGF, for promoting growth of nonleaky vessels.
Journal ArticleDOI

Angiopoietin-1 protects the adult vasculature against plasma leakage.

TL;DR: It is shown that acute administration of angiopoietin-1 does indeed protect adult vasculature from leaking, countering the potentially lethal actions of VEGF and inflammatory agents.
Journal ArticleDOI

Control of vascular morphogenesis and homeostasis through the angiopoietin–Tie system

TL;DR: The Tie receptors and their angiopoietin (Ang) ligands have been identified as the second vascular tissue-specific receptor Tyr kinase system and provide unique insights into the functions of this vascular signalling system.
Related Papers (5)